Additional cytogenetic changes do not influence the outcome of patients with newly diagnosed acute promyelocytic leukemia treated with an ATRA plus anthracycline-based protocol. A report from the spanish group PETHEMA

1. Hernández, J.M.
2. Martín, G.
3. Gutiérrez, N.C.
4. Cervera, J.
5. Ferro, M.T.
6. Calasanz, M.J.
7. Martínez-Climent, J.A.
8. Luño, E.
9. Tormo, M.
10. Rayón, C.
11. Díaz-Mediavilla, J.
12. González, M.
13. González-San Miguel, J.D.
14. Pérez-Equiza, K.
15. Rivas, C.
16. Esteve, J.
17. Del Carmen Alvárez, M.
18. Odriozola, J.
19. Mariá Ribera, J.
20. Sanz, M.A.